News: Life sciences firm Take Solutions appoints new CFO

C-Suite

Life sciences firm Take Solutions appoints new CFO

Lalit comes with over 25+ years of experience in finance & accounts, fund management & budgeting, strategic planning & financial control, merger & acquisitions, forex management etc.
Life sciences firm Take Solutions appoints new CFO

Life sciences service provider TAKE Solutions announced the appointment of Lalit Mahapatra as its Chief Financial Officer.

Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions said, “As the organization goes through a series of management changes, we take this opportunity to strengthen our commitment through these consolidation measures. I am confident Lalit with his strong Finance and Accounting expertise would bring in a fresh perspective and steer in building shareholder value and strengthening governance systems and commercial collaboration in the company.”

Lalit is a Chartered Accountant from the Institute of Chartered Accountants of India, Certified Public Accountant, USA and holds a Diploma in IFRS from ACCA, London. He comes with over 25+ years of experience in finance & accounts, fund management & budgeting, strategic planning & financial control, merger & acquisitions, forex management etc. His previous stints were at organizations such as Price Water House Cooper (PWC), Siemens, and Schneider Electric.

On his appointment, Lalit said, “As we transition through these unprecedented times, I am excited to be taking up this new role at TAKE Solutions. We are equipped with the right strategies to help us move forward in getting us to a profitable shape in the coming quarters. I look forward to creating value for customers, partners, and all shareholders alike.”

Lalit has been the recipient of the CFO of the Year Award in 2013 and 2014. He has also won the Pinnacle Award (Highest Performance Award) in Siemens Worldwide for 'Best Performance towards Business Improvement' in 2006. It is this vast experience the globally recognized life sciences provider is hoping to leverage in these defining times for the pharma industry.

Read full story

Topics: C-Suite, Appointments

Did you find this story helpful?

Author

QUICK POLL

How do you envision AI transforming your work?